107 related articles for article (PubMed ID: 1512711)
1. A correlation with type of sulfonamide resistance gene in Escherichia coli and synergy between trimethoprim and sulfamethoxazole.
Valentine CR; Hawk JM; Christian MM; Youmans RW
J Basic Microbiol; 1992; 32(3):201-7. PubMed ID: 1512711
[TBL] [Abstract][Full Text] [Related]
2. Characterization of trimethoprim-sulfamethoxazole resistance genes and their relatedness to class 1 integron and insertion sequence common region in gram-negative bacilli.
Shin HW; Lim J; Kim S; Kim J; Kwon GC; Koo SH
J Microbiol Biotechnol; 2015 Jan; 25(1):137-42. PubMed ID: 25348695
[TBL] [Abstract][Full Text] [Related]
3. Thermosensitive transfer of antimicrobial resistances and citrate utilization and cotransfer of hydrogen sulfide production from an Escherichia coli isolate.
Harnett N; Mangan L; Brown S; Krishnan C
Diagn Microbiol Infect Dis; 1996 Apr; 24(4):173-8. PubMed ID: 8831030
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-resistant Shigella and enterotoxigenic Escherichia coli strains in children in Thailand.
Chatkaeomorakot A; Echeverria P; Taylor DN; Seriwatana J; Leksomboon U
Pediatr Infect Dis J; 1987 Aug; 6(8):735-9. PubMed ID: 3313233
[TBL] [Abstract][Full Text] [Related]
5. Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole.
Minato Y; Dawadi S; Kordus SL; Sivanandam A; Aldrich CC; Baughn AD
Nat Commun; 2018 Mar; 9(1):1003. PubMed ID: 29520101
[TBL] [Abstract][Full Text] [Related]
6. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
[TBL] [Abstract][Full Text] [Related]
7. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
Moreno E; Prats G; Sabaté M; Pérez T; Johnson JR; Andreu A
J Antimicrob Chemother; 2006 Feb; 57(2):204-11. PubMed ID: 16390858
[TBL] [Abstract][Full Text] [Related]
8. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
[TBL] [Abstract][Full Text] [Related]
9. Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides.
O'Brien TF; Acar JF; Altmann G; Blackburn BO; Chao L; Courtieu AL; Evans DA; Guzman M; Holmes M; Jacobs MR; Kent RL; Norton RA; Koornhof HJ; Medeiros AA; Pasculle AW; Surgalla MJ; Williams JD
Rev Infect Dis; 1982; 4(2):351-7. PubMed ID: 7111960
[TBL] [Abstract][Full Text] [Related]
10. Selection and persistence of antimicrobial-resistant Escherichia coli including extended-spectrum β-lactamase producers in different poultry flocks on one chicken farm.
Schwaiger K; Bauer J; Hölzel CS
Microb Drug Resist; 2013 Dec; 19(6):498-506. PubMed ID: 23844850
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.
Mehta H; Weng J; Prater A; Elworth RAL; Han X; Shamoo Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686152
[No Abstract] [Full Text] [Related]
12. Transferable high-level trimethoprim resistance among isolates of Escherichia coli from urinary tract infections in Ontario, Canada.
Harnett N
Epidemiol Infect; 1992 Dec; 109(3):473-81. PubMed ID: 1468531
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of equine Salmonella strains to trimethoprim and sulfonamide alone or in combination.
van Duijkeren E; van Klingeren B; Vulto AG; Sloet van Oldruitenborgh-Oosterbaan MM; Breukink HJ; van Miert AS
Am J Vet Res; 1994 Oct; 55(10):1386-90. PubMed ID: 7998695
[TBL] [Abstract][Full Text] [Related]
15. Organization of two sulfonamide resistance genes on plasmids of gram-negative bacteria.
Swedberg G
Antimicrob Agents Chemother; 1987 Feb; 31(2):306-11. PubMed ID: 3032095
[TBL] [Abstract][Full Text] [Related]
16. Deletion of
Li K; Li T; Yang SS; Wang XD; Gao LX; Wang RQ; Gu J; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223385
[TBL] [Abstract][Full Text] [Related]
17. Diversity of Plasmids and Antimicrobial Resistance Genes in Multidrug-Resistant Escherichia coli Isolated from Healthy Companion Animals.
Jackson CR; Davis JA; Frye JG; Barrett JB; Hiott LM
Zoonoses Public Health; 2015 Sep; 62(6):479-88. PubMed ID: 25653018
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of in vitro sensitivity testing methods of detecting sulphamethoxazole trimethoprim synergy. Correlation with mouse protection assay.
Rawal BD; Cottis L
Arzneimittelforschung; 1980; 30(7):1049-51. PubMed ID: 6998489
[TBL] [Abstract][Full Text] [Related]
19. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
20. Genetic redundancy and persistence of plasmid-mediated trimethoprim/sulfamethoxazole resistant effluent and stream water Escherichia coli.
Suhartono S; Savin M; Gbur EE
Water Res; 2016 Oct; 103():197-204. PubMed ID: 27455416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]